[go: up one dir, main page]

DK0801559T3 - Fremgangsmåde til fremstilling af orale doseringsformer indeholdende et beta-lactam antibiotikum - Google Patents

Fremgangsmåde til fremstilling af orale doseringsformer indeholdende et beta-lactam antibiotikum

Info

Publication number
DK0801559T3
DK0801559T3 DK96904039T DK96904039T DK0801559T3 DK 0801559 T3 DK0801559 T3 DK 0801559T3 DK 96904039 T DK96904039 T DK 96904039T DK 96904039 T DK96904039 T DK 96904039T DK 0801559 T3 DK0801559 T3 DK 0801559T3
Authority
DK
Denmark
Prior art keywords
pct
beta
lactam antibiotic
preparation
granulate
Prior art date
Application number
DK96904039T
Other languages
Danish (da)
English (en)
Inventor
Koutrik Robertus Cornelis Van
Gerrit Jan Sijbrands
Original Assignee
Yamanouchi Europ Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Europ Bv filed Critical Yamanouchi Europ Bv
Application granted granted Critical
Publication of DK0801559T3 publication Critical patent/DK0801559T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DK96904039T 1995-02-08 1996-02-08 Fremgangsmåde til fremstilling af orale doseringsformer indeholdende et beta-lactam antibiotikum DK0801559T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95200313 1995-02-08
PCT/EP1996/000547 WO1996024337A1 (fr) 1995-02-08 1996-02-08 FORMES GALENIQUES ORALES CONTENANT UN ANTIBIOTIQUE DU TYPE β-LACTAME

Publications (1)

Publication Number Publication Date
DK0801559T3 true DK0801559T3 (da) 2002-06-17

Family

ID=8220003

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96904039T DK0801559T3 (da) 1995-02-08 1996-02-08 Fremgangsmåde til fremstilling af orale doseringsformer indeholdende et beta-lactam antibiotikum

Country Status (19)

Country Link
US (1) US5948422A (fr)
EP (1) EP0801559B1 (fr)
CN (1) CN1125636C (fr)
AT (1) ATE216576T1 (fr)
AU (1) AU4789696A (fr)
BG (1) BG63528B1 (fr)
BR (1) BR9607189A (fr)
CZ (1) CZ293718B6 (fr)
DE (1) DE69620866T2 (fr)
DK (1) DK0801559T3 (fr)
EA (2) EA000361B1 (fr)
ES (1) ES2175073T3 (fr)
HU (1) HU227938B1 (fr)
MX (1) MX9706062A (fr)
NO (1) NO319993B1 (fr)
PL (1) PL186386B1 (fr)
PT (1) PT801559E (fr)
WO (1) WO1996024337A1 (fr)
ZA (1) ZA961018B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI225402B (en) * 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
SK3999A3 (en) 1996-07-16 1999-07-12 Gist Brocades Nv 'beta'-lactam granules free of organic solvents
US6080427A (en) * 1997-04-17 2000-06-27 Bristol-Myers Squibb Company Cefadroxil monohydrate tablet formulation
JP2002505269A (ja) * 1998-03-06 2002-02-19 エウランド インターナショナル ソシエタ ペル アチオニ 急速崩壊錠剤
US7399751B2 (en) * 1999-11-04 2008-07-15 Sertoli Technologies, Inc. Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells
DE19922537A1 (de) * 1999-05-10 2000-11-16 Roland Bodmeier Darreichungsform zur Applikation in Körperöffnungen
US20040034039A1 (en) * 2000-09-22 2004-02-19 Yoshinori Nakano Solid preparations
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US20040213839A1 (en) * 2001-02-05 2004-10-28 Andrew Favara Methods and compositions for reducing the taste of pharmaceutically active agents
RU2190403C1 (ru) * 2001-09-27 2002-10-10 Нестерук Владимир Викторович Фармацевтическая композиция, обладающая антибактериальным действием, и способ ее получения
EP1482789A4 (fr) * 2002-03-12 2010-12-29 Toyama Chemical Company Ltd Suspension orale de gout agreable et procede associe
CN1311831C (zh) * 2002-10-02 2007-04-25 明治制果株式会社 具有改善的口服吸收性的抗菌药物组合物
DE60313216T2 (de) * 2002-12-20 2008-01-03 Niconovum Ab Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose
AU2004266126B8 (en) * 2003-07-03 2011-07-28 Sertoli Technologies, Llc Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants
WO2005021056A1 (fr) * 2003-08-21 2005-03-10 Cns, Inc. Systeme de distribution de materiau effervescent
JP2009515993A (ja) 2005-11-17 2009-04-16 ノバルティス アクチエンゲゼルシャフト 医薬組成物
EP1998748B1 (fr) 2006-03-16 2015-01-14 NicoNovum AB Composition améliorée de tabac à priser
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
US20090191167A1 (en) * 2006-07-28 2009-07-30 Sertocell Biotechnology (Us) Corp. Adult sertoli cells and uses thereof
CA2736531C (fr) * 2008-09-17 2016-10-25 Niconovum Ab Procede de preparation d'une composition de tabac a priser
WO2010077911A1 (fr) * 2008-12-17 2010-07-08 Altheus Therapeutics, Inc. Formules pour lavement
WO2023204773A1 (fr) * 2022-04-20 2023-10-26 Bilim Ilac Sanayii Ve Ticaret A.S. Formulations de comprimés pour le traitement d'infections de l'appareil urinaire et procédé de préparation de telles formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3344030A (en) * 1964-06-15 1967-09-26 American Home Prod Reinforced directly compressed nongranulated pharmaceutical crystalline lactose tables
DE2251249A1 (de) * 1972-10-19 1974-05-02 Hoechst Ag Verfahren zur herstellung von penicillin-verbindungen enthaltenden tabletten
DE2251250C3 (de) * 1972-10-19 1981-06-25 Hoechst Ag, 6230 Frankfurt Verfahren zur Herstellung hochdosierter Antibiotica-Tabletten
ES2061623T3 (es) * 1987-03-02 1994-12-16 Brocades Pharma Bv Procedimiento para la obtencion de una composicion farmaceutica y un granulado farmaceutico.
US5049394A (en) * 1987-09-11 1991-09-17 E. R. Squibb & Sons, Inc. Pharmaceutical composition containing high drug load and method for preparing same
DE68916983T2 (de) * 1988-02-25 1995-01-19 Yamanouchi Europ Bv Verfahren zur Herstellung eines pharmazeutischen Granulats.
US5643591A (en) * 1991-01-16 1997-07-01 Fmc Corporation Solid dosage forms
US5725854A (en) * 1994-04-13 1998-03-10 Research Corporation Technologies, Inc. Methods of treating disease using sertoli cells an allografts or xenografts
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin

Also Published As

Publication number Publication date
EP0801559A1 (fr) 1997-10-22
BG101822A (en) 1998-04-30
BR9607189A (pt) 1997-11-11
MX9706062A (es) 1997-10-31
PL321567A1 (en) 1997-12-08
DE69620866D1 (de) 2002-05-29
WO1996024337A1 (fr) 1996-08-15
NO973646L (no) 1997-09-11
EA199900205A1 (ru) 2000-06-26
HUP9801677A2 (hu) 1998-11-30
CZ293718B6 (cs) 2004-07-14
DE69620866T2 (de) 2003-02-27
PT801559E (pt) 2002-09-30
CZ230297A3 (en) 1997-11-12
EP0801559B1 (fr) 2002-04-24
ATE216576T1 (de) 2002-05-15
BG63528B1 (bg) 2002-04-30
EA003736B1 (ru) 2003-08-28
ES2175073T3 (es) 2002-11-16
US5948422A (en) 1999-09-07
PL186386B1 (pl) 2004-01-30
HUP9801677A3 (en) 1999-05-28
CN1125636C (zh) 2003-10-29
EA199700093A1 (ru) 1998-02-26
CN1173816A (zh) 1998-02-18
ZA961018B (en) 1997-08-08
NO973646D0 (no) 1997-08-07
HU227938B1 (en) 2012-06-28
AU4789696A (en) 1996-08-27
NO319993B1 (no) 2005-10-10
EA000361B1 (ru) 1999-06-24

Similar Documents

Publication Publication Date Title
DK0801559T3 (da) Fremgangsmåde til fremstilling af orale doseringsformer indeholdende et beta-lactam antibiotikum
ATE244004T1 (de) Pharmazeutische zubereitung enthaltend metformin und verfahren zu deren herstellung
MY116124A (en) Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
ZA965237B (en) A composition and a process for the preparation thereof
NO971986L (no) Fremgangsmåte for fremstilling av små partikler
BR9407910A (pt) Composto composiçao farmacêutica uso do composto processo de tratamento de distúrbios no sistema nervoso central e processo de preparaçao do composto
HUT75123A (en) 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivatives
ES2170258T3 (es) Composiciones farmaceuticas con resina de intercambio ionico.
IL115920A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING omega-SUBSTITUTED 2,2-DICHLOROALKANECARBOXYLIC ACIDS, SOME SUCH NEW COMPOUNDS AND PROCESS FOR THEIR PREPARATION
BR9609964A (pt) Formulação sólida estável de sal de enalaprila e processo para preparação da mesma
ATE264332T1 (de) Galanthamin-derivate, verfahren zu ihrer herstellung, ihre verwendung als arzmittel und diese enthaltende pharmazeutische zusammensetzung
HUP9601321A2 (en) Substituted (benzyloxy)-carbonyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them their use as pharmaceutical compositions or diagnostica, and the use of the said compds.
HUP9901260A3 (en) Optically active phenylpyrimidine derivative as analgesic agent, process for producing it, pharmaceutical composition containing it and its intermediate
WO1997010810A3 (fr) Granules pharmaceutiques
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
TNSN00105A1 (fr) Derives de 1-trifluoromethyl-4-hydroxy-7-piperidinyl- aminomethylchromane, procede pour leur preparation et compositions pharmaceutiques les contenant
ATE215941T1 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ES2137665T3 (es) Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
HUT71491A (en) Tablet, capsule, or granule comprising desogestrel and process for preparation thereof
GR74756B (fr)
TW334424B (en) L-arginine aldehyde derivatives process for preparing them and pharmaceutical composition
IL117734A0 (en) Beta-carbolines and pharmaceutical compositions containing them
YU46792B (sh) Kipuća tableta za dezinfekciju vode na bazi hloramina i postupak za njihovu proizvodnju
BR9802588A (pt) Processo para preparação de composições granuladas contendo macrolìdeos de eritromicina e processo para preparação de composições farmaceuticas contendo ditos macrolìdeos.